At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 75 enrolled
Drug / intervention
EV06 Ophthalmic Solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
In Brief
A Phase 2 clinical trial evaluating EV06 Ophthalmic Solution and Placebo Ophthalmic Solution for Presbyopia. Completed, enrolled 75 participants across 4 sites.
Detailed Summary
The purpose of this study is to determine whether EV06 Ophthalmic Solution is safe and effective in improving distance corrected near vision in people who have presbyopia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 2015
Enrollment StartSep 2015
Primary CompletionMar 2016
TodayJul 2026
First PostedAug 5, 2015
Enrollment StartSep 16, 2015
Primary CompletionMar 10, 2016
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.9 years ago
Interventions
EV06 Ophthalmic Solutiondrug
Placebo Ophthalmic Solutiondrug